Biologic therapy for IBD patients through a financial assistance program could have superior outcomes

By | November 24, 2022
Patients with inflammatory bowel diseases (IBD) who required treatment with biologic therapies and were enrolled in a financial assistance program were less likely to need surgery after starting medication than those not enrolled in a program, a study by UT Southwestern researchers found.